China Universal Asset Management Company’s Aquestive Therapeutics AQST Stock Holding History

China Universal Asset Management Company’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.1K	Sell	19,965 -1,685	-8%	-$7.09K	0.01%	427
2026 Q1	$89.8K	Buy	21,650 +1,770	+9%	+$7.18K	0.01%	414
2025 Q4	$128K	Sell	19,880 -1,325	-6%	-$8.26K	0.01%	389
2025 Q3	$119K	Buy	21,205 +1,255	+6%	+$5.43K	0.01%	372
2025 Q2	$66K	Buy	19,950 +1,661	+9%	+$4.76K	0.01%	395
2025 Q1	$53K	Sell	18,289 -1,044	-5%	-$3.16K	﹤0.01%	416
2024 Q4	$68.8K	Buy	+19,333	New	+$89.2K	0.01%	428
2022 Q4	–	Sell	-499	Closed	-$1K	–	398
2022 Q3	$1K	Buy	+499	New	+$564	﹤0.01%	380

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

China Universal Asset Management Company's AQST Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Aquestive Therapeutics (AQST) stake by 7.8% in Q2 2026, selling an estimated $7.09K and leaving 19,965 shares worth $83.1K. The position accounts for 0.01% of the portfolio, ranked #427.

China Universal Asset Management Company first reported a position in AQST in Q3 2022 and has held it in 8 quarters since. The position peaked at $128K in Q4 2025. 103 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

China Universal Asset Management Company held 19,965 shares of Aquestive Therapeutics worth $83.1K as of Q2 2026.
China Universal Asset Management Company sold 1,685 Aquestive Therapeutics shares in Q2 2026, an estimated $7.09K.
Aquestive Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #427 holding.
China Universal Asset Management Company first reported a position in Aquestive Therapeutics in Q3 2022 and has held it in 8 quarters since.
China Universal Asset Management Company's Aquestive Therapeutics position peaked at $128K in Q4 2025.
103 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.